Mangoceuticals (MGRX) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

MGRX Mangoceuticals

Watchlist

2.370
+0.040+1.72%

Trading Nov 19 10:06 ET

5.89MMarket Cap-542P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Mangoceuticals | 10-Q: Q3 2024 Earnings Report
SECNov 14 16:25 ET · Announcements
Mangoceuticals Signs Consulting Deal With CFO Johnston
TipRanksNov 12 17:29 ET
Mangoceuticals Regains Full Compliance With Nasdaq Minimum Bid Price Requirement
BenzingaOct 31 08:39 ET
Express News | Mangoceuticals, Inc. Regains Full Compliance With Nasdaq Minimum Bid Price Requirement
ReutersOct 31 08:00 ET
Update: Mangoceuticals 'Strongly Refutes' Eli Lilly's Claims About Copying Weight-Loss Drugs
MT NewswiresOct 23 06:56 ET
Mangoceuticals Opts For Strategic Alternatives
RTTNewsOct 22 08:27 ET

Comments

Andy-Lai

Nov 11 10:09

JTAl Jet.Al

$Mangoceuticals (MGRX.US)$

JiuShini

Nov 1 09:54

$Mangoceuticals (MGRX.US)$ as expected, regains fully complaince which means they dont have to pump it already, free fall

Trytosaveabit

Oct 31 07:01

Update

$Mangoceuticals (MGRX.US)$ Mangoceuticals, Inc. Regains Full Compliance With Nasdaq Minimum Bid Price Requirement

Jaguar8

Oct 22 07:06

NEWS

$Mangoceuticals (MGRX.US)$
MangoRx Announces Formation of Strategy and Alternatives Committee
MangoRx (NASDAQ: MGRX), a company specializing in men's health and wellness products via telemedicine, has announced the formation of a Strategy and Alternatives Committee. The company's Board of Directors has initiated a process to evaluate potential strategic alternatives aimed at maximizing shareholder value.
These alternatives may include mergers, acquisitions, divestitures, business combinations...

Trytosaveabit

Oct 21 16:24

Summary of new 8K just filed

$Mangoceuticals (MGRX.US)$ On October 21, 2024, Mangoceuticals, Inc., also known as MangoRx, issued a press release to address and counter public claims made by pharmaceutical giant Eli Lilly. The claims pertain to allegations that MangoRx improperly replicated Eli Lilly's weight-loss medication, Zepbound and Mounjaro. MangoRx, listed on NASDAQ under the ticker MGRX, has categorically denied these allegations and has expressed its intention to vigorously defend itself ...

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

MGRX Mangoceuticals

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target